You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The exome-by-phenome-wide analysis uncovered 21 novel gene-phenotype associations, including genes linked to glaucoma and diabetes.
Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
San Francisco Otolaryngology hopes that 2bPrecise's PGx technology can help manage the medication burden on older patients and improve symptoms of dementia.
In PLOS this week: method that combines genetic and lab test results from EHRs, leptospirosis microtranscriptome profiles, and more.
The project will result in the creation of a national cohort for research, as well as an integrated clinical and genomic data infrastructure at the national level.
To support the 1+ Million Genomes Initiative, the EC has funded a new project, called Beyond 1 Million Genomes, with €4 million over the next three years.
The analysis drew on thousands of cases and controls and suggested a role for an autoimmune factor in penicillin allergies.
In a newly published paper, CHOP researchers described a method for rebuilding patient histories en masse to create gene-specific "footprints" in clinical records.
The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.